Butyrate Reprograms Expression of Specific Interferon-Stimulated Genes

Butyrate is an abundant metabolite produced by gut microbiota. While butyrate is a known histone deacetylase inhibitor that activates expression of many genes involved in immune system pathways, its effects on virus infections and on the antiviral type I interferon (IFN) response have not been adequ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of virology 2020-07, Vol.94 (16)
Hauptverfasser: Chemudupati, Mahesh, Kenney, Adam D, Smith, Anna C, Fillinger, Robert J, Zhang, Lizhi, Zani, Ashley, Liu, Shan-Lu, Anderson, Matthew Z, Sharma, Amit, Yount, Jacob S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 16
container_start_page
container_title Journal of virology
container_volume 94
creator Chemudupati, Mahesh
Kenney, Adam D
Smith, Anna C
Fillinger, Robert J
Zhang, Lizhi
Zani, Ashley
Liu, Shan-Lu
Anderson, Matthew Z
Sharma, Amit
Yount, Jacob S
description Butyrate is an abundant metabolite produced by gut microbiota. While butyrate is a known histone deacetylase inhibitor that activates expression of many genes involved in immune system pathways, its effects on virus infections and on the antiviral type I interferon (IFN) response have not been adequately investigated. We found that butyrate increases cellular infection with viruses relevant to human and animal health, including influenza virus, reovirus, HIV-1, human metapneumovirus, and vesicular stomatitis virus. Mechanistically, butyrate suppresses levels of specific antiviral IFN-stimulated gene (ISG) products, such as RIG-I and IFITM3, in human and mouse cells without inhibiting IFN-induced phosphorylation or nuclear translocation of the STAT1 and STAT2 transcription factors. Accordingly, we discovered that although butyrate globally increases baseline expression of more than 800 cellular genes, it strongly represses IFN-induced expression of 60% of ISGs and upregulates 3% of ISGs. Our findings reveal that there are differences in the IFN responsiveness of major subsets of ISGs depending on the presence of butyrate in the cell environment, and overall, they identify a new mechanism by which butyrate influences virus infection of cells. Butyrate is a lipid produced by intestinal bacteria. Here, we newly show that butyrate reprograms the innate antiviral immune response mediated by type I interferons (IFNs). Many of the antiviral genes induced by type I IFNs are repressed in the presence of butyrate, resulting in increased virus infection and replication. Our research demonstrates that metabolites produced by the gut microbiome, such as butyrate, can have complex effects on cellular physiology, including dampening of an inflammatory innate immune pathway resulting in a proviral cellular environment. Our work further suggests that butyrate could be broadly used as a tool to increase growth of virus stocks for research and for the generation of vaccines.
doi_str_mv 10.1128/JVI.00326-20
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7394905</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>32461320</sourcerecordid><originalsourceid>FETCH-LOGICAL-c497t-ce14c062b96ba8924e6c8a7dd988cae5a91481d54c14dd99075b5ad00e3696673</originalsourceid><addsrcrecordid>eNpVkE1Lw0AQhhdRbK3ePEt-gKmzn8leBC1trQiCVfG2bDaTGmmTsJuK_fdGq0VPAzPv-ww8hJxSGFLK0ovb59kQgDMVM9gjfQo6jaWkYp_0ARiLJU9feuQohDcAKoQSh6THmVCUM-iTyfW63XjbYvSAja8X3q5CNP5oPIZQ1lVUF9G8QVcWpYtmVYu-QF9X8bwtV-tlV8ujKVYYjslBYZcBT37mgDxNxo-jm_jufjobXd3FTuikjR1S4UCxTKvMppoJVC61SZ7rNHUWpdVUpDSXwlHRLTUkMpM2B0CutFIJH5DLLbdZZyvMHVatt0vT-HJl_cbUtjT_L1X5ahb1u0m4FhpkBzjfApyvQ_BY7LoUzJdP0_k03z4Ngy5-9vffLvwrkH8C3LVyTQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Butyrate Reprograms Expression of Specific Interferon-Stimulated Genes</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Chemudupati, Mahesh ; Kenney, Adam D ; Smith, Anna C ; Fillinger, Robert J ; Zhang, Lizhi ; Zani, Ashley ; Liu, Shan-Lu ; Anderson, Matthew Z ; Sharma, Amit ; Yount, Jacob S</creator><creatorcontrib>Chemudupati, Mahesh ; Kenney, Adam D ; Smith, Anna C ; Fillinger, Robert J ; Zhang, Lizhi ; Zani, Ashley ; Liu, Shan-Lu ; Anderson, Matthew Z ; Sharma, Amit ; Yount, Jacob S</creatorcontrib><description>Butyrate is an abundant metabolite produced by gut microbiota. While butyrate is a known histone deacetylase inhibitor that activates expression of many genes involved in immune system pathways, its effects on virus infections and on the antiviral type I interferon (IFN) response have not been adequately investigated. We found that butyrate increases cellular infection with viruses relevant to human and animal health, including influenza virus, reovirus, HIV-1, human metapneumovirus, and vesicular stomatitis virus. Mechanistically, butyrate suppresses levels of specific antiviral IFN-stimulated gene (ISG) products, such as RIG-I and IFITM3, in human and mouse cells without inhibiting IFN-induced phosphorylation or nuclear translocation of the STAT1 and STAT2 transcription factors. Accordingly, we discovered that although butyrate globally increases baseline expression of more than 800 cellular genes, it strongly represses IFN-induced expression of 60% of ISGs and upregulates 3% of ISGs. Our findings reveal that there are differences in the IFN responsiveness of major subsets of ISGs depending on the presence of butyrate in the cell environment, and overall, they identify a new mechanism by which butyrate influences virus infection of cells. Butyrate is a lipid produced by intestinal bacteria. Here, we newly show that butyrate reprograms the innate antiviral immune response mediated by type I interferons (IFNs). Many of the antiviral genes induced by type I IFNs are repressed in the presence of butyrate, resulting in increased virus infection and replication. Our research demonstrates that metabolites produced by the gut microbiome, such as butyrate, can have complex effects on cellular physiology, including dampening of an inflammatory innate immune pathway resulting in a proviral cellular environment. Our work further suggests that butyrate could be broadly used as a tool to increase growth of virus stocks for research and for the generation of vaccines.</description><identifier>ISSN: 0022-538X</identifier><identifier>EISSN: 1098-5514</identifier><identifier>DOI: 10.1128/JVI.00326-20</identifier><identifier>PMID: 32461320</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>Animals ; Antiviral Agents - pharmacology ; Butyrates - metabolism ; Butyrates - pharmacology ; Cell Line ; Cellular Response to Infection ; Gene Expression - drug effects ; Gene Expression - genetics ; Humans ; Immunity, Innate - drug effects ; Interferon Type I - drug effects ; Interferon Type I - metabolism ; Interferons - metabolism ; Membrane Proteins - metabolism ; Mice ; RNA-Binding Proteins - metabolism ; Signal Transduction - drug effects ; STAT1 Transcription Factor - metabolism ; STAT2 Transcription Factor - metabolism ; Virus Diseases ; Virus Replication - drug effects</subject><ispartof>Journal of virology, 2020-07, Vol.94 (16)</ispartof><rights>Copyright © 2020 American Society for Microbiology.</rights><rights>Copyright © 2020 American Society for Microbiology. 2020 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c497t-ce14c062b96ba8924e6c8a7dd988cae5a91481d54c14dd99075b5ad00e3696673</citedby><cites>FETCH-LOGICAL-c497t-ce14c062b96ba8924e6c8a7dd988cae5a91481d54c14dd99075b5ad00e3696673</cites><orcidid>0000-0003-1683-2170</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394905/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394905/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32461320$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chemudupati, Mahesh</creatorcontrib><creatorcontrib>Kenney, Adam D</creatorcontrib><creatorcontrib>Smith, Anna C</creatorcontrib><creatorcontrib>Fillinger, Robert J</creatorcontrib><creatorcontrib>Zhang, Lizhi</creatorcontrib><creatorcontrib>Zani, Ashley</creatorcontrib><creatorcontrib>Liu, Shan-Lu</creatorcontrib><creatorcontrib>Anderson, Matthew Z</creatorcontrib><creatorcontrib>Sharma, Amit</creatorcontrib><creatorcontrib>Yount, Jacob S</creatorcontrib><title>Butyrate Reprograms Expression of Specific Interferon-Stimulated Genes</title><title>Journal of virology</title><addtitle>J Virol</addtitle><description>Butyrate is an abundant metabolite produced by gut microbiota. While butyrate is a known histone deacetylase inhibitor that activates expression of many genes involved in immune system pathways, its effects on virus infections and on the antiviral type I interferon (IFN) response have not been adequately investigated. We found that butyrate increases cellular infection with viruses relevant to human and animal health, including influenza virus, reovirus, HIV-1, human metapneumovirus, and vesicular stomatitis virus. Mechanistically, butyrate suppresses levels of specific antiviral IFN-stimulated gene (ISG) products, such as RIG-I and IFITM3, in human and mouse cells without inhibiting IFN-induced phosphorylation or nuclear translocation of the STAT1 and STAT2 transcription factors. Accordingly, we discovered that although butyrate globally increases baseline expression of more than 800 cellular genes, it strongly represses IFN-induced expression of 60% of ISGs and upregulates 3% of ISGs. Our findings reveal that there are differences in the IFN responsiveness of major subsets of ISGs depending on the presence of butyrate in the cell environment, and overall, they identify a new mechanism by which butyrate influences virus infection of cells. Butyrate is a lipid produced by intestinal bacteria. Here, we newly show that butyrate reprograms the innate antiviral immune response mediated by type I interferons (IFNs). Many of the antiviral genes induced by type I IFNs are repressed in the presence of butyrate, resulting in increased virus infection and replication. Our research demonstrates that metabolites produced by the gut microbiome, such as butyrate, can have complex effects on cellular physiology, including dampening of an inflammatory innate immune pathway resulting in a proviral cellular environment. Our work further suggests that butyrate could be broadly used as a tool to increase growth of virus stocks for research and for the generation of vaccines.</description><subject>Animals</subject><subject>Antiviral Agents - pharmacology</subject><subject>Butyrates - metabolism</subject><subject>Butyrates - pharmacology</subject><subject>Cell Line</subject><subject>Cellular Response to Infection</subject><subject>Gene Expression - drug effects</subject><subject>Gene Expression - genetics</subject><subject>Humans</subject><subject>Immunity, Innate - drug effects</subject><subject>Interferon Type I - drug effects</subject><subject>Interferon Type I - metabolism</subject><subject>Interferons - metabolism</subject><subject>Membrane Proteins - metabolism</subject><subject>Mice</subject><subject>RNA-Binding Proteins - metabolism</subject><subject>Signal Transduction - drug effects</subject><subject>STAT1 Transcription Factor - metabolism</subject><subject>STAT2 Transcription Factor - metabolism</subject><subject>Virus Diseases</subject><subject>Virus Replication - drug effects</subject><issn>0022-538X</issn><issn>1098-5514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkE1Lw0AQhhdRbK3ePEt-gKmzn8leBC1trQiCVfG2bDaTGmmTsJuK_fdGq0VPAzPv-ww8hJxSGFLK0ovb59kQgDMVM9gjfQo6jaWkYp_0ARiLJU9feuQohDcAKoQSh6THmVCUM-iTyfW63XjbYvSAja8X3q5CNP5oPIZQ1lVUF9G8QVcWpYtmVYu-QF9X8bwtV-tlV8ujKVYYjslBYZcBT37mgDxNxo-jm_jufjobXd3FTuikjR1S4UCxTKvMppoJVC61SZ7rNHUWpdVUpDSXwlHRLTUkMpM2B0CutFIJH5DLLbdZZyvMHVatt0vT-HJl_cbUtjT_L1X5ahb1u0m4FhpkBzjfApyvQ_BY7LoUzJdP0_k03z4Ngy5-9vffLvwrkH8C3LVyTQ</recordid><startdate>20200730</startdate><enddate>20200730</enddate><creator>Chemudupati, Mahesh</creator><creator>Kenney, Adam D</creator><creator>Smith, Anna C</creator><creator>Fillinger, Robert J</creator><creator>Zhang, Lizhi</creator><creator>Zani, Ashley</creator><creator>Liu, Shan-Lu</creator><creator>Anderson, Matthew Z</creator><creator>Sharma, Amit</creator><creator>Yount, Jacob S</creator><general>American Society for Microbiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1683-2170</orcidid></search><sort><creationdate>20200730</creationdate><title>Butyrate Reprograms Expression of Specific Interferon-Stimulated Genes</title><author>Chemudupati, Mahesh ; Kenney, Adam D ; Smith, Anna C ; Fillinger, Robert J ; Zhang, Lizhi ; Zani, Ashley ; Liu, Shan-Lu ; Anderson, Matthew Z ; Sharma, Amit ; Yount, Jacob S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c497t-ce14c062b96ba8924e6c8a7dd988cae5a91481d54c14dd99075b5ad00e3696673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animals</topic><topic>Antiviral Agents - pharmacology</topic><topic>Butyrates - metabolism</topic><topic>Butyrates - pharmacology</topic><topic>Cell Line</topic><topic>Cellular Response to Infection</topic><topic>Gene Expression - drug effects</topic><topic>Gene Expression - genetics</topic><topic>Humans</topic><topic>Immunity, Innate - drug effects</topic><topic>Interferon Type I - drug effects</topic><topic>Interferon Type I - metabolism</topic><topic>Interferons - metabolism</topic><topic>Membrane Proteins - metabolism</topic><topic>Mice</topic><topic>RNA-Binding Proteins - metabolism</topic><topic>Signal Transduction - drug effects</topic><topic>STAT1 Transcription Factor - metabolism</topic><topic>STAT2 Transcription Factor - metabolism</topic><topic>Virus Diseases</topic><topic>Virus Replication - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chemudupati, Mahesh</creatorcontrib><creatorcontrib>Kenney, Adam D</creatorcontrib><creatorcontrib>Smith, Anna C</creatorcontrib><creatorcontrib>Fillinger, Robert J</creatorcontrib><creatorcontrib>Zhang, Lizhi</creatorcontrib><creatorcontrib>Zani, Ashley</creatorcontrib><creatorcontrib>Liu, Shan-Lu</creatorcontrib><creatorcontrib>Anderson, Matthew Z</creatorcontrib><creatorcontrib>Sharma, Amit</creatorcontrib><creatorcontrib>Yount, Jacob S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chemudupati, Mahesh</au><au>Kenney, Adam D</au><au>Smith, Anna C</au><au>Fillinger, Robert J</au><au>Zhang, Lizhi</au><au>Zani, Ashley</au><au>Liu, Shan-Lu</au><au>Anderson, Matthew Z</au><au>Sharma, Amit</au><au>Yount, Jacob S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Butyrate Reprograms Expression of Specific Interferon-Stimulated Genes</atitle><jtitle>Journal of virology</jtitle><addtitle>J Virol</addtitle><date>2020-07-30</date><risdate>2020</risdate><volume>94</volume><issue>16</issue><issn>0022-538X</issn><eissn>1098-5514</eissn><abstract>Butyrate is an abundant metabolite produced by gut microbiota. While butyrate is a known histone deacetylase inhibitor that activates expression of many genes involved in immune system pathways, its effects on virus infections and on the antiviral type I interferon (IFN) response have not been adequately investigated. We found that butyrate increases cellular infection with viruses relevant to human and animal health, including influenza virus, reovirus, HIV-1, human metapneumovirus, and vesicular stomatitis virus. Mechanistically, butyrate suppresses levels of specific antiviral IFN-stimulated gene (ISG) products, such as RIG-I and IFITM3, in human and mouse cells without inhibiting IFN-induced phosphorylation or nuclear translocation of the STAT1 and STAT2 transcription factors. Accordingly, we discovered that although butyrate globally increases baseline expression of more than 800 cellular genes, it strongly represses IFN-induced expression of 60% of ISGs and upregulates 3% of ISGs. Our findings reveal that there are differences in the IFN responsiveness of major subsets of ISGs depending on the presence of butyrate in the cell environment, and overall, they identify a new mechanism by which butyrate influences virus infection of cells. Butyrate is a lipid produced by intestinal bacteria. Here, we newly show that butyrate reprograms the innate antiviral immune response mediated by type I interferons (IFNs). Many of the antiviral genes induced by type I IFNs are repressed in the presence of butyrate, resulting in increased virus infection and replication. Our research demonstrates that metabolites produced by the gut microbiome, such as butyrate, can have complex effects on cellular physiology, including dampening of an inflammatory innate immune pathway resulting in a proviral cellular environment. Our work further suggests that butyrate could be broadly used as a tool to increase growth of virus stocks for research and for the generation of vaccines.</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>32461320</pmid><doi>10.1128/JVI.00326-20</doi><orcidid>https://orcid.org/0000-0003-1683-2170</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-538X
ispartof Journal of virology, 2020-07, Vol.94 (16)
issn 0022-538X
1098-5514
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7394905
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Animals
Antiviral Agents - pharmacology
Butyrates - metabolism
Butyrates - pharmacology
Cell Line
Cellular Response to Infection
Gene Expression - drug effects
Gene Expression - genetics
Humans
Immunity, Innate - drug effects
Interferon Type I - drug effects
Interferon Type I - metabolism
Interferons - metabolism
Membrane Proteins - metabolism
Mice
RNA-Binding Proteins - metabolism
Signal Transduction - drug effects
STAT1 Transcription Factor - metabolism
STAT2 Transcription Factor - metabolism
Virus Diseases
Virus Replication - drug effects
title Butyrate Reprograms Expression of Specific Interferon-Stimulated Genes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T18%3A34%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Butyrate%20Reprograms%20Expression%20of%20Specific%20Interferon-Stimulated%20Genes&rft.jtitle=Journal%20of%20virology&rft.au=Chemudupati,%20Mahesh&rft.date=2020-07-30&rft.volume=94&rft.issue=16&rft.issn=0022-538X&rft.eissn=1098-5514&rft_id=info:doi/10.1128/JVI.00326-20&rft_dat=%3Cpubmed_cross%3E32461320%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32461320&rfr_iscdi=true